Glucagon Regulation of Energy Expenditure
Open accessThe DOI matches its Crossref record; 93 of the 93 references it cites were found in a registry or an index.
Abstract
Glucagon’s ability to increase energy expenditure has been known for more than 60 years, yet the mechanisms underlining glucagon’s thermogenic effect still remain largely elusive. Over the last years, significant efforts were directed to unravel the physiological and cellular underpinnings of how glucagon regulates energy expenditure. In this review, we summarize the current knowledge on how glucagon regulates systems metabolism with a special emphasis on its acute and chronic thermogenic effects.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures


Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Unimolecular co-agonists of GLP-1R and the glucagon receptor (GcgR) were the first to emerge, seeking to leverage the anorectic and anti-diabetic effects of GLP-1 with the ability of Gcg to increase energy expenditure [[17], [18], [19]]”
From Next generation GLP-1/GIP/glucagon triple agonists normalize body weight in obese mice (2022) · cites this paper as [18]
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In animal models, glucagon stimulates energy expenditure through activation of brown adipose tissue [68], although the significance of this effect has not been confirmed by human data [69].”
From New Developments in Pharmacological Treatment of Obesity and Type 2 Diabetes—Beyond and within GLP-1 Receptor Agonists (2024) · cites this paper as [68]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Beyond the role of glucagon in glucose homeostasis, there are additional metabolic effects; these include increasing satiety and reducing food intake, as well as effects on lipid homeostasis and the increase of energy expenditure [8,9].”
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“germline Gipr-deficient mice are protected from diet-induced obesity103”
From Transforming obesity: The advancement of multi-receptor drugs (2024) · cites this paper as [103]
Experimental — accuracy not yet measuredIn the citing paper
“Glucagon (GCG) is a 29 amino acid peptide secreted by pancreatic α cells when blood glucose levels are low. Its ability to increase energy expenditure has been known for over 60 years (125).”
From GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach (2023) · cites this paper as [125]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Brown Adipose Tissue: Function and Physiological Significance
CANNON, B., & NEDERGAARD, J. (2004) · Physiological Reviews · doi:10.1152/physrev.00015.2003 · Cited by 6,433
Identification and Importance of Brown Adipose Tissue in Adult Humans
Cypess, A. M., Lehman, S., Williams, G., Tal, I., Rodman, D., Goldfine, A. B., Kuo, F. C., Palmer, E. L., Tseng, Y.-H., Doria, A., et al. (2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810780 · Cited by 4,399
Activation of Human Brown Adipose Tissue by a β3-Adrenergic Receptor Agonist
Cypess, A. M., Weiner, L. S., Roberts-Toler, C., Elía, E. F., Kessler, S. H., Kahn, P. A., English, J., Chatman, K., Trauger, S. A., Doria, A., et al. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2014.12.009 · Cited by 1,027
Mechanism of Fatty-Acid-Dependent UCP1 Uncoupling in Brown Fat Mitochondria
Fedorenko, A., Lishko, P. V., & Kirichok, Y. (2012) · Cell · doi:10.1016/j.cell.2012.09.010 · Cited by 968 · cited 1×
“UCP1 uncouples oxidative phosphorylation from ATP synthesis with the result that energy form substrate oxidation is released as heat [48,49].”
BackgroundUnderstanding the Physiology of FGF21
Fisher, F. M., & Maratos-Flier, E. (2016) · Annual Review of Physiology · doi:10.1146/annurev-physiol-021115-105339 · Cited by 912 · cited 2×
“In the liver, glucagon stimulates the synthesis and release of fibroblast growth factor 21 (FGF21) [34,76], a circulating peptide hormone that regulates energy homeostasis [77,78] and is primarily derived from the liver [35,79] (Figure 2).”
BackgroundGlucagon and regulation of glucose metabolism
Jiang, G., & Zhang, B. B. (2003) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00492.2002 · Cited by 905
A guide to analysis of mouse energy metabolism
Tschöp, M. H., Speakman, J. R., Arch, J. R. S., Auwerx, J., Brüning, J. C., Chan, L., Eckel, R. H., Farese, R. V., Galgani, J. E., Hambly, C., et al. (2012) · Nature Methods · doi:10.1038/nmeth.1806 · Cited by 813
Self-citationA new glucagon and GLP-1 co-agonist eliminates obesity in rodents
Day, J. W., Ottaway, N., Patterson, J. T., Gelfanov, V., Smiley, D., Gidda, J., Findeisen, H., Bruemmer, D., Drucker, D. J., Chaudhary, N., et al. (2009) · Nature Chemical Biology · doi:10.1038/nchembio.209 · Cited by 641
Self-citationThe essential role of glucagon in the pathogenesis of diabetes mellitus
Unger, R., & Orci, L. (1975) · The Lancet · doi:10.1016/s0140-6736(75)92375-2 · Cited by 599
Circulating FGF21 Is Liver Derived and Enhances Glucose Uptake During Refeeding and Overfeeding
Markan, K. R., Naber, M. C., Ameka, M. K., Anderegg, M. D., Mangelsdorf, D. J., Kliewer, S. A., Mohammadi, M., & Potthoff, M. J. (2014) · Diabetes · doi:10.2337/db14-0595 · Cited by 590 · cited 2×
“In the liver, glucagon stimulates the synthesis and release of fibroblast growth factor 21 (FGF21) [34,76], a circulating peptide hormone that regulates energy homeostasis [77,78] and is primarily derived from the liver [35,79] (Figure 2).”
BackgroundFGF21 acts centrally to induce sympathetic nerve activity, energy expenditure, and weight loss
Owen, B. M., Ding, X., Morgan, D. A., Coate, K. C., Bookout, A. L., Rahmouni, K., Kliewer, S. A., & Mangelsdorf, D. J. (2014) · Cell Metabolism · doi:10.1016/j.cmet.2014.07.012 · Cited by 523 · cited 2×
“This suggests that Fgf21 increases energy expenditure via centrally mediated mechanisms [81,82] (Figure 2).”
BackgroundGlucagon-Like Peptide 1/Glucagon Receptor Dual Agonism Reverses Obesity in Mice
Pocai, A., Carrington, P. E., Adams, J. R., Wright, M., Eiermann, G., Zhu, L., Du, X., Petrov, A., Lassman, M. E., Jiang, G., et al. (2009) · Diabetes · doi:10.2337/db09-0278 · Cited by 409
The metabolic actions of glucagon revisited
Habegger, K. M., Heppner, K. M., Geary, N., Bartness, T. J., DiMarchi, R., & Tschöp, M. H. (2010) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2010.187 · Cited by 406
Self-citationFGF21 Regulates Metabolism Through Adipose-Dependent and -Independent Mechanisms
BonDurant, L. D., Ameka, M., Naber, M. C., Markan, K. R., Idiga, S. O., Acevedo, M. R., Walsh, S. A., Ornitz, D. M., & Potthoff, M. J. (2017) · Cell Metabolism · doi:10.1016/j.cmet.2017.03.005 · Cited by 330
Peptides and the blood-brain barrier: Lipophilicity as a predictor of permeability
Banks, W. A., & Kastin, A. J. (1985) · Brain Research Bulletin · doi:10.1016/0361-9230(85)90153-4 · Cited by 306
Ambery, P., Parker, V. E., Stumvoll, M., Posch, M. G., Heise, T., Plum-Moerschel, L., Tsai, L.-F., Robertson, D., Jain, M., Petrone, M., et al. (2018) · The Lancet · doi:10.1016/s0140-6736(18)30726-8 · Cited by 298
Physiologic action of glucagon on liver glucose metabolism
Ramnanan, C. J., Edgerton, D. S., Kraft, G., & Cherrington, A. D. (2011) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2011.01454.x · Cited by 293 · cited 1×
“Glucagon is well known to elevate the circulating pool of glucose via its hepatic actions [51].”
BackgroundPancreatic signals controlling food intake; insulin, glucagon and amylin
Woods, S. C., Lutz, T. A., Geary, N., & Langhans, W. (2006) · Philosophical Transactions of the Royal Society B: Biological Sciences · doi:10.1098/rstb.2006.1858 · Cited by 277
Islet α cells and glucagon--critical regulators of energy homeostasis
Campbell, J. E., & Drucker, D. J. (2015) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.51 · Cited by 266
Tan, T. M., Field, B. C. T., McCullough, K. A., Troke, R. C., Chambers, E. S., Salem, V., Gonzalez Maffe, J., Baynes, K. C. R., De Silva, A., Viardot, A., et al. (2013) · Diabetes · doi:10.2337/db12-0797 · Cited by 258
Cardiovascular effects of glucagon in man
Parmley, W. W., Glick, G., & Sonnenblick, E. H. (1968) · New England Journal of Medicine · doi:10.1056/nejm196807042790103 · Cited by 246 · cited 1×
“In rats, blood flow into BAT increases following glucagon administration [43], which is in accordance to glucagon’s effect on vasodilation [44] and cardiac output [45,46].”
BackgroundFibroblast Growth Factor 21 Mediates Specific Glucagon Actions
Habegger, K. M., Stemmer, K., Cheng, C., Müller, T. D., Heppner, K. M., Ottaway, N., Holland, J., Hembree, J. L., Smiley, D., Gelfanov, V., et al. (2013) · Diabetes · doi:10.2337/db12-1116 · Cited by 245
Self-citationHenderson, S. J., Konkar, A., Hornigold, D. C., Trevaskis, J. L., Jackson, R., Fritsch Fredin, M., Jansson‐Löfmark, R., Naylor, J., Rossi, A., Bednarek, M. A., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12735 · Cited by 240
Lockie, S. H., Heppner, K. M., Chaudhary, N., Chabenne, J. R., Morgan, D. A., Veyrat-Durebex, C., Ananthakrishnan, G., Rohner-Jeanrenaud, F., Drucker, D. J., DiMarchi, R., et al. (2012) · Diabetes · doi:10.2337/db11-1556 · Cited by 237
Glucagon Receptor Signaling and Lipid Metabolism
Galsgaard, K. D., Pedersen, J., Knop, F. K., Holst, J. J., & Wewer Albrechtsen, N. J. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00413 · Cited by 218 · cited 2×
“The GcgR is also expressed in the white adipose tissue (WAT) of rodents (~100× higher than in BAT) and humans [5].”
BackgroundCentral Fibroblast Growth Factor 21 Browns White Fat via Sympathetic Action in Male Mice
Douris, N., Stevanovic, D. M., Fisher, F. M., Cisu, T. I., Chee, M. J., Nguyen, N. L., Zarebidaki, E., Adams, A. C., Kharitonenkov, A., Flier, J. S., et al. (2015) · Endocrinology · doi:10.1210/en.2014-2001 · Cited by 215 · cited 2×
“This suggests that Fgf21 increases energy expenditure via centrally mediated mechanisms [81,82] (Figure 2).”
BackgroundKazda, C. M., Ding, Y., Kelly, R. P., Garhyan, P., Shi, C., Lim, C. N., Fu, H., Watson, D. E., Lewin, A. J., Landschulz, W. H., et al. (2016) · Diabetes Care · doi:10.2337/dc15-1643 · Cited by 212
Petersen, K. F., & Sullivan, J. T. (2001) · Diabetologia · doi:10.1007/s001250100006 · Cited by 209
Effect of cortisol on energy expenditure and amino acid metabolism in humans
Brillon, D. J., Zheng, B., Campbell, R. G., & Matthews, D. E. (1995) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1995.268.3.e501 · Cited by 206
Liang, Y., Osborne, M. C., Monia, B. P., Bhanot, S., Gaarde, W. A., Reed, C., She, P., Jetton, T. L., & Demarest, K. T. (2004) · Diabetes · doi:10.2337/diabetes.53.2.410 · Cited by 202
Finan, B., Clemmensen, C., Zhu, Z., Stemmer, K., Gauthier, K., Müller, L., De Angelis, M., Moreth, K., Neff, F., Perez-Tilve, D., et al. (2016) · Cell · doi:10.1016/j.cell.2016.09.014 · Cited by 191
Self-citationChristiansen, J. J., Djurhuus, C. B., Gravholt, C. H., Iversen, P., Christiansen, J. S., Schmitz, O., Weeke, J., Jørgensen, J. O. L., & Møller, N. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0445 · Cited by 176
Guzman, C. B., Zhang, X. M., Liu, R., Regev, A., Shankar, S., Garhyan, P., Pillai, S. G., Kazda, C., Chalasani, N., & Hardy, T. A. (2017) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12958 · Cited by 172 · cited 2×
“However adverse effects such as increased hepatic fat accumulation and increased LDL cholesterol have been reported for these antagonists in humans [20,21].”
BackgroundGluconeogenesis and energy expenditure after a high-protein, carbohydrate-free diet
Veldhorst, M. A., Westerterp-Plantenga, M. S., & Westerterp, K. R. (2009) · The American Journal of Clinical Nutrition · doi:10.3945/ajcn.2009.27834 · Cited by 170
Glucagon increases energy expenditure independently of brown adipose tissue activation in humans
Salem, V., Izzi‐Engbeaya, C., Coello, C., Thomas, D. B., Chambers, E. S., Comninos, A. N., Buckley, A., Win, Z., Al‐Nahhas, A., Rabiner, E. A., et al. (2016) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.12585 · Cited by 167
Hyperglycemia of Diabetic Rats Decreased by a Glucagon Receptor Antagonist
Johnson, D. G., Goebel, C. U., Hruby, V. J., Bregman, M. D., & Trivedi, D. (1982) · Science · doi:10.1126/science.6278587 · Cited by 166
Glucagon lowers glycemia when β cells are active
Capozzi, M. E., Wait, J. B., Koech, J., Gordon, A. N., Coch, R. W., Svendsen, B., Finan, B., D’Alessio, D. A., & Campbell, J. E. (2019) · JCI Insight · doi:10.1172/jci.insight.129954 · Cited by 165
Fibroblast growth factor-21, energy balance and obesity
Giralt, M., Gavaldà‐Navarro, A., & Villarroya, F. (2015) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2015.09.018 · Cited by 161
Hepatic FXR: key regulator of whole-body energy metabolism
Teodoro, J. S., Rolo, A. P., & Palmeira, C. M. (2011) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2011.07.002 · Cited by 157
Carr, R. D., Larsen, M. O., Jelic, K., Lindgren, O., Vikman, J., Holst, J. J., Deacon, C. F., & Ahrén, B. (2010) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2009-2054 · Cited by 154
Stimulation of Feeding in Rats by Intraperitoneal Injection of Antibodies to Glucagon
Langhans, W., Zeiger, U., Scharrer, E., & Geary, N. (1982) · Science · doi:10.1126/science.7134979 · Cited by 151
Hyperglucagonemia increases resting metabolic rate in man during insulin deficiency
NAIR, K. S. (1987) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem-64-5-896 · Cited by 141
Minireview: Glucagon in Stress and Energy Homeostasis
Jones, B. J., Tan, T., & Bloom, S. R. (2012) · Endocrinology · doi:10.1210/en.2011-1979 · Cited by 140
Selective hepatic vagotomy blocks pancreatic glucagon's satiety effect
GEARY, N., & SMITH, G. (1983) · Physiology & Behavior · doi:10.1016/0031-9384(83)90207-x · Cited by 134 · cited 1×
“The satiety effect of glucagon is likely mediated via the liver-vagus-hypothalamus axis, since disconnection of the hepatic branch of the abdominal vagus nerve blocks glucagon’s anorectic effect [8].”
BackgroundHypothalamic glucagon signaling inhibits hepatic glucose production
Mighiu, P. I., Yue, J. T. Y., Filippi, B., Abraham, M. A., Chari, M., Lam, C., Yang, C. S., Christian, N. R., Charron, M. J., & Lam, T. K. T. (2013) · Nature Medicine · doi:10.1038/nm.3115 · Cited by 131
Treatment of severe diabetic hypoglycemia with glucagon: an underutilized therapeutic approach
Kedia (2011) · Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy · doi:10.2147/dmso.s20633 · Cited by 131
Evidence for a catabolic role of glucagon during an amino acid load.
Charlton, M., Adey, D., & Nair, K. S. (1996) · Journal of Clinical Investigation · doi:10.1172/jci118782 · Cited by 130
Heim, T., & Hull, D. (1966) · The Journal of Physiology · doi:10.1113/jphysiol.1966.sp008088 · Cited by 124
Farah, A. E. (1983) · Pharmacological Reviews · doi:10.1016/s0031-6997(25)06576-7 · Cited by 122
Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
Finan, B., Capozzi, M. E., & Campbell, J. E. (2020) · Diabetes · doi:10.2337/dbi19-0004 · Cited by 118
Identification of glucagon receptors in rat brain.
Hoosein, N. M., & Gurd, R. S. (1984) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.81.14.4368 · Cited by 110
Wu, C., Kang, J., Peng, L.-J., Li, H., Khan, S. A., Hillard, C. J., Okar, D. A., & Lange, A. J. (2005) · Cell Metabolism · doi:10.1016/j.cmet.2005.07.003 · Cited by 109
Stimulation of Metabolism of Rat Brown Adipose Tissue by Addition of Lipolytic Hormones in Vitro
Joel, C. D. (1966) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)96838-9 · Cited by 102
Design of Novel Exendin-Based Dual Glucagon-like Peptide 1 (GLP-1)/Glucagon Receptor Agonists
Evers, A., Haack, T., Lorenz, M., Bossart, M., Elvert, R., Henkel, B., Stengelin, S., Kurz, M., Glien, M., Dudda, A., et al. (2017) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.7b00174 · Cited by 101
KUROSHIMA, A., & YAHATA, T. (1979) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.29.683 · Cited by 100
Rao, R. H., & Spathis, G. S. (1987) · Metabolism · doi:10.1016/0026-0495(87)90150-8 · Cited by 98
Magnusson, I., Rothman, D. L., Gerard, D. P., Katz, L. D., & Shulman, G. I. (1995) · Diabetes · doi:10.2337/diab.44.2.185 · Cited by 97
Kim, T., Nason, S., Holleman, C., Pepin, M., Wilson, L., Berryhill, T. F., Wende, A. R., Steele, C., Young, M. E., Barnes, S., et al. (2018) · Diabetes · doi:10.2337/db17-1502 · Cited by 97
Self-citationInsulin and the paraventricular hypothalamus: modulation of energy balance
Menéndez, J., & Atrens, D. M. (1991) · Brain Research · doi:10.1016/0006-8993(91)90342-s · Cited by 92
Bagger, J. I., Holst, J. J., Hartmann, B., Andersen, B., Knop, F. K., & Vilsbøll, T. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-2335 · Cited by 88
Beaudry, J. L., Kaur, K. D., Varin, E. M., Baggio, L. L., Cao, X., Mulvihill, E. E., Stern, J. H., Campbell, J. E., Scherer, P. E., & Drucker, D. J. (2019) · Molecular Metabolism · doi:10.1016/j.molmet.2019.01.011 · Cited by 88
Metabolic effects of glucagon in the Wistar rat
SALTER, J. M. (1960) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/8.5.535 · Cited by 85 · cited 2×
“The pioneering pair-feeding study of Salter in 1960 indicated that the chronic GcgR agonism regulates bodyweight via both food intake dependent and independent mechanisms [30].”
BackgroundSørensen, H., Brand, C. L., Neschen, S., Holst, J. J., Fosgerau, K., Nishimura, E., & Shulman, G. I. (2006) · Diabetes · doi:10.2337/db06-0222 · Cited by 80
Cyphert, H. A., Alonge, K. M., Ippagunta, S. M., & Hillgartner, F. B. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094996 · Cited by 79
Glucagon stimulation of brown adipose tissue growth and thermogenesis
Billington, C. J., Bartness, T. J., Briggs, J., Levine, A. S., & Morley, J. E. (1987) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1987.252.1.r160 · Cited by 78
Glucagon receptor antagonism induces increased cholesterol absorption
Guan, H.-P., Yang, X., Lu, K., Wang, S.-P., Castro-Perez, J. M., Previs, S., Wright, M., Shah, V., Herath, K., Xie, D., et al. (2015) · Journal of Lipid Research · doi:10.1194/jlr.m060897 · Cited by 76 · cited 2×
“However adverse effects such as increased hepatic fat accumulation and increased LDL cholesterol have been reported for these antagonists in humans [20,21].”
BackgroundGlucagon: acute actions on hepatic metabolism
Miller, R., & Birnbaum, M. J. (2016) · Diabetologia · doi:10.1007/s00125-016-3955-y · Cited by 75
Role of cortisol in the metabolic response to stress hormone infusion in the conscious dog
Fujiwara, T., Cherrington, A. D., Neal, D. W., & McGuinness, O. P. (1996) · Metabolism · doi:10.1016/s0026-0495(96)90026-8 · Cited by 71
Glucagon in physiological concentrations stimulates brown fat thermogenesis in vivo
Billington, C. J., Briggs, J. E., Link, J. G., & Levine, A. S. (1991) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1991.261.2.r501 · Cited by 71
The Effect of Glucagon on the Metabolic Rate of Rats
Davidson, I. W. F., Salter, J., & BEST, C. H. (1960) · American Journal of Clinical Nutrition · doi:10.1093/ajcn/8.5.540 · Cited by 70
Lefebvre, P., Luyckx, A., & Bacq, Z. (1973) · Hormone and Metabolic Research · doi:10.1055/s-0028-1093959 · Cited by 64
Mu, J., Jiang, G., Brady, E. J., Dallas-Yang, Q., Liu, F., Woods, J., Zycband, E., Wright, M., Li, Z., Lü, K., et al. (2011) · Diabetologia · doi:10.1007/s00125-011-2217-2 · Cited by 64
Richter, W. O., Robl, H., & SCHWANDT, P. (1989) · Peptides · doi:10.1016/0196-9781(89)90039-9 · Cited by 54
Insulin dissociates hepatic glucose cycling and glucagon-induced thermogenesis in man
Calles-Escandón, J. (1994) · Metabolism · doi:10.1016/0026-0495(94)90180-5 · Cited by 52
Rauch, T., Graefe-Mody, U., Deacon, C. F., Ring, A., Holst, J. J., Woerle, H.-J., Dugi, K. A., & Heise, T. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0010-y · Cited by 51
Amigo, I., Traba, J., González‐Barroso, M. M., Rueda, C. B., Fernández, M., Rial, E., Sánchez, A., Satrústegui, J., & del Arco, A. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.409144 · Cited by 51
Apparent thermogenic effect of injected glucagon is not due to a direct effect on brown fat cells
Dicker, A., Zhao, J., Cannon, B., & Nedergaard, J. (1998) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1998.275.5.r1674 · Cited by 50
Does glucagon have a positive inotropic effect in the human heart?
Hernández-Cascales, J. (2018) · Cardiovascular Diabetology · doi:10.1186/s12933-018-0791-z · Cited by 47
Glucagon-like Substance in the Canine Brain
Sasaki, H., EBITANI, I., Tominaga, M., Yamatani, K., YAWATA, Y., & HARA, M. (1980) · Endocrinologia Japonica · doi:10.1507/endocrj1954.27.supplement_135 · Cited by 44
Foster, D. W., & McGarry, J. D. (1982) · Novartis Foundation Symposia · doi:10.1002/9780470720691.ch7 · Cited by 38
Loose-coupled mitochondria in chronic glucagon-treated hyperthermic ducklings
Barré, H., Berne, G., Brebion, P., Cohen-Adad, F., & Rouanet, J. L. (1989) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.1989.256.6.r1192 · Cited by 36
THE EFFECT OF LIPOLYTIC HORMONES AND THEOPHYLLINE ON HEAT PRODUCTION IN BROWN ADIPOSE TISSUEIN VIVO
Cockburn, F., Hull, D., & Walton, I. (1967) · British Journal of Pharmacology and Chemotherapy · doi:10.1111/j.1476-5381.1967.tb00421.x · Cited by 34
Hypothalamic glucagon signals through the KATP channels to regulate glucose production
Abraham, M. A., Yue, J. T. Y., LaPierre, M. P., Rutter, G. A., Light, P. E., Filippi, B. M., & Lam, T. K. T. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2013.11.007 · Cited by 34
Suppression of weight gain by glucagon in obese Zucker rats
Chan, E. K., MACKEY, M. A., Snover, D. C., Schneider, P. D., Rucker, R. D., Allen, C. E., & Buchwald, H. (1984) · Experimental and Molecular Pathology · doi:10.1016/0014-4800(84)90049-2 · Cited by 31
YAHATA, T., HABARA, Y., & KUROSHIMA, A. (1983) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.33.367 · Cited by 29
LaPierre, M. P., Abraham, M. A., Yue, J. T. Y., Filippi, B., & Lam, T. K. T. (2015) · EMBO Reports · doi:10.15252/embr.201540492 · Cited by 27
Thermogenic response to glucagon in cold-acclimated mice.
Doi, K., & KUROSHIMA, A. (1982) · The Japanese Journal of Physiology · doi:10.2170/jjphysiol.32.377 · Cited by 24
Metabolic Effects of Glucagon in the Young Pig
Ingram, D., & Kaciuba-Uscilko, H. (1980) · Hormone and Metabolic Research · doi:10.1055/s-2007-999167 · Cited by 20
Glucagon and the paraventricular hypothalamus: modulation of energy balance
Atrens, D. M., & Menéndez, J. (1993) · Brain Research · doi:10.1016/0006-8993(93)90663-8 · Cited by 19
Stahel, P., Lee, S. J., Sud, S. K., Floh, A., & Dash, S. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13661 · Cited by 18
McGuinness, O. P., Murrell, S., Moran, C., Bracy, D. P., & Cherrington, A. D. (1994) · Metabolism · doi:10.1016/0026-0495(94)90228-3 · Cited by 14
Calorigenic Effects of Glucagon and Epinephrine in Anesthetized Dogs
Weiser, P. C., & Grande, F. (1974) · Experimental Biology and Medicine · doi:10.3181/00379727-145-37923 · Cited by 14
Effect of injected glucagon or fatty acids on mitochondrial ATPase
López-Moratalla, N., Funes, T., Garrido, B., de Manzanos, T. F., & Santiago, E. (1984) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(84)90144-9 · Cited by 4
Cited by
Triple-Hormone-Receptor Agonist Retatrutide for Obesity — A Phase 2 Trial
Jastreboff, A. M., Kaplan, L. M., Frías, J. P., Wu, Q., Du, Y., Gurbuz, S., Coskun, T., Haupt, A., Milicevic, Z., & Hartman, M. L. (2023) · New England Journal of Medicine · doi:10.1056/nejmoa2301972 · Cited by 1,174
Anti-obesity drug discovery: advances and challenges
Müller, T. D., Blüher, M., Tschöp, M. H., & DiMarchi, R. D. (2022) · Nature Reviews Drug Discovery · doi:10.1038/s41573-021-00337-8 · Cited by 1,021
Self-citationRosenstock, J., Frias, J., Jastreboff, A. M., Du, Y., Lou, J., Gurbuz, S., Thomas, M. K., Hartman, M. L., Haupt, A., Milicevic, Z., et al. (2023) · The Lancet · doi:10.1016/s0140-6736(23)01053-x · Cited by 423
Coskun, T., Urva, S., Roell, W. C., Qu, H., Loghin, C., Moyers, J. S., O’Farrell, L. S., Briere, D. A., Sloop, K. W., Thomas, M. K., et al. (2022) · Cell Metabolism · doi:10.1016/j.cmet.2022.07.013 · Cited by 316
Sanyal, A. J., Kaplan, L. M., Frias, J. P., Brouwers, B., Wu, Q., Thomas, M. K., Harris, C., Schloot, N. C., Du, Y., Mather, K. J., et al. (2024) · Nature Medicine · doi:10.1038/s41591-024-03018-2 · Cited by 315
Metadata
- Authors
- Kleinert, M., Sachs, S., Habegger, K. M., Hofmann, S. M., & Müller, T. D.
- Affiliations
- University of Copenhagen (DK)
- Helmholtz Munich (DE)
- University of Alabama at Birmingham (US)
- Corresponding author
- Müller, Timo D.
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2019-10-30
- Volume
- 20
- Issue
- 21
- Pages
- 5407
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC6862306
- OpenAlex
- W2982363774
- Cited by
- 147
- References
- 93
- Citations by year
- 2026: 19 · 2025: 29 · 2024: 27 · 2023: 33 · 2022: 20 · 2021: 12 · 2020: 7
- FWCI
- 1.16
- Type
- journal article
- Language
- en
- Open access
- gold
- dx.doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Research at the University of Copenhagen (University of Copenhagen) (publishedVersion, cc-by)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion, other-oa)
- Site cant be reached (submittedVersion, cc-by)
- PuSH - Publication Server of Helmholtz Zentrum München (submittedVersion, cc-by)
- Funders
- Sanofi
- Deutsche Forschungsgemeinschaft (TRR- 152, SFB/TRR152, SFB TRR 152/2)
- Lundbeckfonden (R288-2018-78)
- Novo Nordisk
- Servier
- National Institutes of Health
- National Institute of Diabetes and Digestive and Kidney Diseases (R01DK112934, P30DK056336, P30DK079626)
- Topics
- Health Sciences › Medicine › Physiology (medical) › Adipose Tissue and Metabolism
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Neuroscience › Endocrine and Autonomic Systems › Regulation of Appetite and Obesity
- Keywords
- glucagon, energy expenditure, thermogenesis, thermogenic effect, cellular mechanisms
- MeSH terms
- Animals, Energy Metabolism, Glucagon, Humans, Thermogenesis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.